Green Cross Health Limited (NZX: GXH) has reported a Net Profit After Tax Attributable to Shareholders of $24.6 million, a 47% increase from the prior year.
The Group, behind Unichem and Life Pharmacy, The Doctors and Access Community Health, saw strong performance across all three divisions, as well as in-year acquisition activity.
Retail sales, script volumes and loyalty memberships were consistent year-on-year, while medical revenue and operating profit were up 35% and 71% respectively.
The Company has declared a final FY22 dividend of 3.5 cents per share, with expectations for FY23 to return to pre-COVID-19 profitability levels.
See more
